NCT05961982View on ClinicalTrials.gov

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

NARecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Pancreatic Neoplasm
Interventions
PROCEDURE

Chemical Ablation

Undergo EUS-guided chemoablation

PROCEDURE

Computed Tomography

Undergo CT

OTHER

Electronic Health Record Review

Ancillary studies

PROCEDURE

Endoscopic Ultrasound-Guided Fine-Needle Aspiration

Undergo EUS-FNA

PROCEDURE

Endoscopic Ultrasound-Guided Radiofrequency Ablation

Undergo EUS-RFA

PROCEDURE

Magnetic Resonance Cholangiopancreatography

Undergo MRI/MRCP

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI/MRCP

Trial Locations (1)

43210

RECRUITING

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER